AstraZeneca traint 17.000 werknemers in AI voor omzetdoel van 80 miljard dollar

AstraZeneca has certified over 17,000 employees in AI competencies as part of its strategy to reach an ambitious $80 billion revenue target by 2030. The biopharmaceutical company operates approximately 1,000 active AI pilots and is exploring both generative and agentic AI applications to scale operations. Finance leadership plays a critical role in prioritizing which pilots should transition to production, with the company aiming to nearly double its size through growth in existing products, expansion into new indications, and pipeline assets.